New Life to Desmoteplase Moving to Clinical Phase III

Hee-Sook Christensen
Hee-Sook Christensen
  • 15 years ago
Lundbeck has initiated a clinical phase III programme with desmoteplase in the treatment of acute ischemic stroke. Anders Gersel Pedersen, Executive Vice President, Drug Development at Lundbeck explains.

Recommended

1:03
I
Up next
Lundbeck Initiate New Products Division
Hee-Sook Christensen
1:13
Getting Through the Financial Crisis
Hee-Sook Christensen
2:52
New Center for Antimicrobial Research
Hee-Sook Christensen
2:22
Wyeth Pharmaceuticals and Santaris Pharma Announce ...
Hee-Sook Christensen
2:15
Cholesterol is Crucial for Insulin Secretion
Hee-Sook Christensen
3:49
Pfizer to Acquire Wyeth
Hee-Sook Christensen
1:26
Vampire Bat Behind Science
Hee-Sook Christensen
5:14
Research Infrastructure for Life Science
Hee-Sook Christensen
2:06
Novo A/S Launches a New Investing Initiative
Hee-Sook Christensen
1:32
CellaVision's US Subsidiary Receives Important Orders
Hee-Sook Christensen
1:12
ACADIA Awarded Grant from The Michael J. Fox Foundation
Hee-Sook Christensen
2:47
Leonardo BioCulture Project
Hee-Sook Christensen
1:08
Strategy On Track
Hee-Sook Christensen
2:00
Exiqon Launch New Colon Cancer Test
Hee-Sook Christensen
2:41
New Research Center in Copenhagen
Hee-Sook Christensen
2:29
Symphogen and Meiji Seika Kaisha Ltd. Achieve Milestone ...
Hee-Sook Christensen
2:08
New Way to Predict Type 2 Diabetes
Hee-Sook Christensen
2:17
First Danish Biotech Report from Ernst & Young
Hee-Sook Christensen
4:17
Japanese Pharma Visits Medicon Valley
Hee-Sook Christensen
1:20
Commitum Awarded Best New Company in Sweden 2008
Hee-Sook Christensen
2:24
Lund Scientist Behind New Migraine Medicine
Hee-Sook Christensen
3:45
Unlocking the Secrets of Blod Cell Therapy
Hee-Sook Christensen
2:00
University Research Facilities in a Poor Condition
Hee-Sook Christensen
2:40
Race for Future Research Cornerstone
Hee-Sook Christensen
2:16
News from MVA’s Life Science Ambassador in Japan
Hee-Sook Christensen